Total Payments
$87,100
2024 Payments
$15,614
Companies
21
Transactions
299
Medicare Patients
11,958
Medicare Billing
$9.4M
Payment Breakdown by Category
Other$28,868 (33.1%)
Research$24,074 (27.6%)
Consulting$19,368 (22.2%)
Food & Beverage$9,620 (11.0%)
Travel$5,170 (5.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $28,868 | 6 | 33.1% |
| Unspecified | $24,074 | 13 | 27.6% |
| Consulting Fee | $19,368 | 4 | 22.2% |
| Food and Beverage | $9,620 | 261 | 11.0% |
| Travel and Lodging | $5,170 | 15 | 5.9% |
Payments by Type
General
$63,026
286 transactions
Research
$24,074
5 transactions
Ownership
$0
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $28,868 | 14 | $0 (2024) |
| Genentech USA, Inc. | $17,035 | 56 | $0 (2024) |
| Allergan, Inc. | $16,924 | 47 | $0 (2021) |
| Alimera Sciences, Inc. | $13,186 | 28 | $0 (2024) |
| Genentech, Inc. | $4,064 | 21 | $0 (2019) |
| Regeneron Pharmaceuticals, Inc. | $1,994 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,574 | 50 | $0 (2024) |
| Alcon Vision LLC | $537.82 | 7 | $0 (2022) |
| ABBVIE INC. | $524.32 | 12 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $427.86 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,614 | 38 | Alimera Sciences, Inc. ($12,658) |
| 2023 | $9,061 | 25 | Genentech USA, Inc. ($8,648) |
| 2022 | $18,124 | 45 | US Retina LLC ($9,250) |
| 2021 | $13,503 | 20 | US Retina LLC ($12,942) |
| 2020 | $3,278 | 23 | US Retina LLC ($2,888) |
| 2019 | $6,673 | 50 | US Retina LLC ($3,788) |
| 2018 | $1,940 | 46 | Genentech, Inc. ($974.19) |
| 2017 | $18,907 | 52 | Allergan Inc. ($16,097) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: EYE CARE | ||||||
| 11/20/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/19/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/08/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/04/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Ophthalmology | ||||||
| 10/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $35.08 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Ophthalmology | ||||||
| 10/02/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: Ophthalmology | ||||||
| 08/21/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Ophthalmology | ||||||
| 08/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/25/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug) | — | Cash or cash equivalent | $1,097.28 | Research |
| Study: Iluvien Study • Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 07/24/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Ophthalmology | ||||||
| 07/15/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $34.22 | General |
| Category: Ophthalmology | ||||||
| 07/01/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: EYE CARE | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.30 | General |
| Category: Ophthalmology | ||||||
| 06/06/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $142.97 | General |
| Category: Ophthalmology | ||||||
| 06/05/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/30/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Ophthalmology | ||||||
| 04/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $37.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/27/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Iluvien Study | Alimera Sciences, Inc. | $12,590 | 4 |
| A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration | Allergan Inc. | $11,484 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,976 | 45,287 | $11.1M | $2.6M |
| 2022 | 19 | 3,156 | 14,195 | $10.6M | $2.5M |
| 2021 | 19 | 2,995 | 9,667 | $8.9M | $2.2M |
| 2020 | 18 | 2,831 | 9,275 | $8.0M | $2.1M |
Total Patients
11,958
Total Services
78,424
Medicare Billing
$9.4M
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 128 | 37,200 | $4.0M | $1.1M | 27.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 152 | 1,464 | $3.1M | $1.0M | 32.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 48 | 930 | $1.0M | $166,279 | 16.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 341 | 1,463 | $2.2M | $144,502 | 6.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 661 | 867 | $221,085 | $79,476 | 35.9% |
| 92134 | Imaging of retina | Office | 2023 | 855 | 2,225 | $287,025 | $70,323 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 171 | 171 | $68,400 | $20,712 | 30.3% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 12 | 119 | $42,036 | $17,622 | 41.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 173 | 227 | $39,725 | $15,899 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 162 | $25,110 | $11,548 | 46.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 35 | 135 | $40,500 | $7,134 | 17.6% |
| 92250 | Photography of the retina | Office | 2023 | 178 | 224 | $44,800 | $6,241 | 13.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 22 | 23 | $8,050 | $2,389 | 29.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $6,300 | $1,950 | 31.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 30 | $4,200 | $1,180 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $2,475 | $1,133 | 45.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 19 | 24 | $8,664 | $854.70 | 9.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 188 | 2,047 | $4.3M | $1.5M | 33.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 93 | 2,101 | $2.3M | $462,314 | 20.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 351 | 1,550 | $2.3M | $152,382 | 6.7% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 35 | 4,081 | $444,263 | $121,782 | 27.4% |
| J3590 | Unclassified biologics | Office | 2022 | 22 | 54 | $347,706 | $98,078 | 28.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 675 | 877 | $223,635 | $79,483 | 35.5% |
| 92134 | Imaging of retina | Office | 2022 | 872 | 2,300 | $296,700 | $72,656 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 260 | 260 | $104,000 | $30,655 | 29.5% |
About Dr. Robert Stoltz, MD
Dr. Robert Stoltz, MD is a Specialist healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275584047.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Stoltz, MD has received a total of $87,100 in payments from pharmaceutical and medical device companies, with $15,614 received in 2024. These payments were reported across 299 transactions from 21 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($28,868).
As a Medicare-enrolled provider, Stoltz has provided services to 11,958 Medicare beneficiaries, totaling 78,424 services with total Medicare billing of $9.4M. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Marietta, GA
- Active Since 05/15/2006
- Last Updated 02/12/2010
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1275584047
Products in Payments
- ILUVIEN (Drug) $12,590
- Vabysmo (Drug) $8,724
- VABYSMO (Drug) $7,446
- OZURDEX (Drug) $5,820
- Non-Covered Product (Drug) $1,947
- EYLEA HD (Biological) $1,898
- Lucentis (Biological) $1,015
- EYLEA (Biological) $860.82
- EYLEA AFLIBERCEPT INJECTION (Biological) $808.90
- Syfovre (Drug) $405.38
- Iluvien (Drug) $343.42
- Constellation (Device) $336.24
- XIPERE (Drug) $287.80
- YUTIQ (Drug) $248.26
- Cimerli (Biological) $245.22
- BEOVU (Drug) $229.73
- NGENUITY (Device) $172.58
- ACTHAR (Biological) $151.76
- Izervay (Drug) $138.71
- CLARUS 700 (Device) $133.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Marietta
James Hammesfahr, M.d, M.D
Specialist — Payments: $24,486
Specialist $24,486
Dr. Edward Himot, M.d, M.D
Specialist — Payments: $7,481
Specialist $7,481
Dr. Vijay Nath, M.d, M.D
Specialist — Payments: $5,911
Specialist $5,911
Dr. Sandeep Jaglan, M.d, M.D
Specialist — Payments: $5,604
Specialist $5,604
Dr. Akin Ogundipe, M.d, M.D
Specialist — Payments: $5,437
Specialist $5,437
Dr. Madhuri Meka, Md, MD
Specialist — Payments: $3,067
Specialist $3,067